Advanced Medical Solutions Group (LSE:AMS) Short Interest


LSE:AMS Advanced Medical Solutions Group PLC LSE:AMS
89 GF Score
Price £2.79
GF Value £3.69
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


LSE:AMS vs ISRG, BDX, MDLN: Short Interest Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Short Interest falls into.


LSE:AMS
89GF Score
Advanced Medical Solutions Group PLC LSE:AMS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Advanced Medical Solutions Group (LSE:AMS) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.79 is trading 24.5% below its estimated GF Value™ of £3.69. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for LSE:AMS:

  • Short Interest:
  • GF Value™: £3.69 vs. price of £2.79 (24.5% below fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the LSE:AMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMSl:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
89GF Score

Get the complete analysis for LSE:AMS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.79
Price
£3.69
GF Value